Radiotherapy and Oncology10.1016/s0167-8140(04)80476-6200471S37-S3897 poster National patterns of care study about postoperative keloid prophylaxis,
European Journal of Cancer10.1016/s0959-8049(99)81287-8199935S220Preoperative radiotherapy is better than postoperative in rectal cancerL. Påhlman,
Radiotherapy and Oncology10.1016/s0167-8140(99)00138-31999533177-187Late complications after a combined pre and postoperative (sandwich) radiotherapy for rectal cancerVladimir Svoboda, Hans-Peter Beck-Bornholdt, Thomas Herrmann, Winfried Alberti, Horst Jung,
Radiotherapy and Oncology10.1016/s0167-8140(04)82556-8200473S299688 poster Prospective study of postoperative simultaneous integrated boost (SIB) intensity-modulated radiotherapy for patients with head-and-neck cancers,
Radiotherapy and Oncology10.1016/s0167-8140(04)80357-8200471S132308 poster Treatment of unresectable rectal cancers,
Radiotherapy and Oncology10.1016/0167-8140(96)01775-61996402127-135Adjuvant postoperative radiotherapy in rectal cancer: 148 cases treated at Florence University with 8 years median follow-upL. Cionini, S. Marzano, L. Boffi, G. Cardona, F. Ficari, C. Fucini, F. Tonelli,
European Journal of Cancer Supplements10.1016/s1359-6349(05)81435-1200532329-3301141 POSTER Postoperative radiotherapy (PORT) for non-small-cell lung cancer (NSCLC): Results of the 1999–2001 patterns of care study (PCS) nationwide process survey in Japan,
Radiotherapy and Oncology10.1016/s0167-8140(99)00117-6199953153-573D-recurrence-patterns of gliobastomas after CT-planned postoperative irradiationUlrich Oppitz, Dirk Maessen, Hildegard Zunterer, Susanne Richter, Michael Flentje,
Radiotherapy and Oncology10.1016/0167-8140(88)90219-81988134245-252Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: A review of the gastrointestinal tumor study group experiencePatrick R.M. Thomas, Anne S. Lindblad,
Radiotherapy and Oncology10.1016/j.radonc.2018.05.00420181273392-395Preoperative radiotherapy or chemoradiotherapy in rectal cancer – Is survival improved? An update of the “Nordic” LARC study in non-resectable cancersMorten Brændengen, Bengt Glimelius,